Trial Profile
Pragmatic cluster randomised controlled trial to evaluate the effectiveness and cost effectiveness of inhaled methoxyflurane (Penthrox) versus usual analgesia for prehospital injury and trauma
Status:
Discontinued
Phase of Trial:
Phase III/IV
Latest Information Update: 04 Jul 2022
Price :
$35
*
At a glance
- Drugs Methoxyflurane (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms MAPIT
- 04 Nov 2019 Status changed from completed to discontinued.
- 10 Jan 2018 New trial record
- 08 Jan 2018 Status changed from active, no longer recruiting to completed.